Prognostic value of indoleamine 2, 3-dioxygenase-1 expression in glial tumors.

Munir Kaya Asude Aksoy Gökhan Artaş Metin Kaplan

Published in: Ideggyogyaszati szemle (2023)

<p>IDO-1 expression is an independent prognostic biomarker to predict <br>OS and progression in HGG. IDO-1 can be evaluated as an alternative instrument for precision medicine in the treatment of gliomas.</p>.

Keyphrases

poor prognosis
binding protein
long non coding rna
combination therapy